Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130)
- PMID: 1419621
- PMCID: PMC1977989
- DOI: 10.1038/bjc.1992.361
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130)
Abstract
The metabolism of cholesterol has been investigated in tumour cells, ascitic fluid and blood serum during the growth of an ascites hepatoma (Yoshida AH-130) in the rat. High rates of cholesterol synthesis and elevated free and esterified cholesterol content were observed in tumour cells. During tumour growth, the host animals progressively developed marked changes in the level and distribution of serum cholesterol consisting in an increase of total cholesterol and of a marked reduction of HDL cholesterol (HDL2 subfraction in particular). In agreement with previous observations, these findings indicate that a consistent pattern of altered cholesterol homeostasis develops in relation to normal or neoplastic tissue growth. High synthetic rates and intracellular accumulation of cholesterol are observed in the proliferating cells. Moreover, blood serum cholesterol decreases in the HDL fraction while it increases in LDLs, suggesting that during proliferative processes cholesterol fluxes between tissues and serum lipoproteins are markedly perturbed.
Similar articles
-
Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).Br J Cancer. 1995 Nov;72(5):1138-43. doi: 10.1038/bjc.1995.477. Br J Cancer. 1995. PMID: 7577459 Free PMC article.
-
Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin.J Nutr. 1999 Mar;129(3):700-6. doi: 10.1093/jn/129.3.700. J Nutr. 1999. PMID: 10082777
-
Humoral mediation for cachexia in tumour-bearing rats.Br J Cancer. 1993 Jan;67(1):15-23. doi: 10.1038/bjc.1993.4. Br J Cancer. 1993. PMID: 8427775 Free PMC article.
-
Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats.Biosci Biotechnol Biochem. 2004 Jan;68(1):72-8. doi: 10.1271/bbb.68.72. Biosci Biotechnol Biochem. 2004. PMID: 14745166
-
A flow cytometric study of the rat Yoshida AH-130 ascites hepatoma.Cancer Lett. 1993 Aug 31;72(3):169-73. doi: 10.1016/0304-3835(93)90124-r. Cancer Lett. 1993. PMID: 8402587
Cited by
-
Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.Mol Cell Endocrinol. 2010 Oct 7;327(1-2):1-12. doi: 10.1016/j.mce.2010.06.013. Epub 2010 Jun 30. Mol Cell Endocrinol. 2010. PMID: 20600583 Free PMC article. Review.
-
Lipid levels in serum and cancerous tissues of colorectal cancer patients.World J Gastroenterol. 2014 Jul 14;20(26):8646-52. doi: 10.3748/wjg.v20.i26.8646. World J Gastroenterol. 2014. PMID: 25024621 Free PMC article.
-
Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).Br J Cancer. 1995 Nov;72(5):1138-43. doi: 10.1038/bjc.1995.477. Br J Cancer. 1995. PMID: 7577459 Free PMC article.
-
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.J Clin Invest. 1995 May;95(5):2367-72. doi: 10.1172/JCI117929. J Clin Invest. 1995. PMID: 7738199 Free PMC article.
-
A lipoprotein source of cholesteryl esters is essential for proliferation of CEM-CCRF lymphoblastic cell line.Tumour Biol. 2012 Apr;33(2):443-53. doi: 10.1007/s13277-011-0270-6. Epub 2011 Dec 10. Tumour Biol. 2012. PMID: 22161086
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical